TrialClinical lung cancer2021

Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).

Jonathan W Riess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.